The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow IPOs

By The Online Investor Staff, updated Thu., Feb. 11, 1:21 AM

Slide #1. Editas Medicine, Inc. Initial Public Offering

Company: Editas Medicine, Inc.
Proposed Symbol: EDIT
Shares Offered: 5,900,000
Price Per Share: $16.00
Over-Allotment: 885,000
Description: Editas Medicine, Inc., a leading genome editing company, today announced the pricing of its initial public offering of 5,900,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. All of the shares are being offered by Editas Medicine. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 885,000 shares of common stock from Editas Medicine at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The company's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading on Wednesday, February 3, 2016 under the ticker symbol "EDIT."

IPOs: Editas Medicine, Inc.

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Noble Midstream Partners LP             NBLX      
Xtera Communications, Inc.              XCOM      
Instructure                             INST      
Mesoblast Limited                       MESO      
Mimecast Limited                        MIME      
Match Group, Inc.                       MTCH      
Square, Inc.                            SQ        
Duluth Holdings Inc.                    DLTH      
Kitov Pharmaceuticals Holdings Ltd.     KTOV      
Atlassian                               TEAM      
Yirendai Ltd.                           YRD       
China Customer Relations Centers, Inc.  CCRC      
Advanced Disposal Services, Inc.        ADSW      
BeiGene, Ltd.                           BGNE      
Editas Medicine, Inc.                   EDIT      

February 11, 2016    1:21 AM Eastern

IPOs | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.